Skip to main content
. 2016 Sep 1;11(9):e0161753. doi: 10.1371/journal.pone.0161753

Fig 2. Local and systemic reactinogenicity by treatment group.

Fig 2

Local and systemic reactinogenicity for the pooled placebo and each vaccine regimen (T1-T4) are shown in the top and bottom panel respectively. None, mild, moderate and severe reactions are colour coded blue, yellow, orange and red respectively. T1: MVA prime, sequential gp140 boost (M/M/P/P); T2 (MP/MP): concurrent MVA/gp140; T3 (D/D/M/M): DNA prime, sequential MVA boost; T4 (D/D/MP/MP): DNA prime, concurrent MVA/gp140 boost) or placebo. Two-sided unadjusted p-values from Fisher’s exact tests were used to compare proportions of participants that had local or systemic reactions between each pair of vaccine arms.